Publisher Full Text
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.Cell Res. 2020 03; 30(3):269-271.CR
Links
MeSH
Adenosine MonophosphateAlanineAnimalsAntimalarialsAntiviral AgentsBetacoronavirusBiological AssayCOVID-19Chlorocebus aethiopsChloroquineCoronavirus InfectionsDrug DiscoveryDrug Evaluation, PreclinicalHumansMiddle East Respiratory Syndrome CoronavirusPneumonia, ViralSARS VirusSARS-CoV-2SincalideVero Cells
Pub Type(s)
Letter
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
32020029
Clinical Trial Links
Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial
PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine
Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections
Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting
Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19
Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)
Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh
Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)
Citation
Wang, Manli, et al. "Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-nCoV) in Vitro." Cell Research, vol. 30, no. 3, 2020, pp. 269-271.
Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-271.
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269-271. https://doi.org/10.1038/s41422-020-0282-0
Wang M, et al. Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-nCoV) in Vitro. Cell Res. 2020;30(3):269-271. PubMed PMID: 32020029.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
AU - Wang,Manli,
AU - Cao,Ruiyuan,
AU - Zhang,Leike,
AU - Yang,Xinglou,
AU - Liu,Jia,
AU - Xu,Mingyue,
AU - Shi,Zhengli,
AU - Hu,Zhihong,
AU - Zhong,Wu,
AU - Xiao,Gengfu,
Y1 - 2020/02/04/
PY - 2020/01/25/received
PY - 2020/01/28/accepted
PY - 2020/2/6/pubmed
PY - 2020/3/24/medline
PY - 2020/2/6/entrez
SP - 269
EP - 271
JF - Cell research
JO - Cell Res
VL - 30
IS - 3
SN - 1748-7838
UR - https://www.unboundmedicine.com/medline/citation/32020029/full_citation
L2 - https://doi.org/10.1038/s41422-020-0282-0
DB - PRIME
DP - Unbound Medicine
ER -